Robichaud Albert 4
4 · Sage Therapeutics, Inc. · Filed Feb 15, 2022
Insider Transaction Report
Form 4
Robichaud Albert
Chief Scientific Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-02-11+13,300→ 13,300 totalExercise: $43.04Exp: 2032-02-11→ Common Stock (13,300 underlying)
Footnotes (1)
- [F1]The securities awarded on February 11, 2022 were in the form of stock options issued pursuant to the Sage Therapeutics, Inc. 2014 Stock Option and Incentive Plan. Options to purchase 3,325 shares of common stock shall vest on the one year anniversary of February 11, 2022, with 9,975 shares vesting in 36 equal monthly installments thereafter.